Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin ...

The bridge aims to prevent the extinction of local mountain lions by allowing them to breed with other populations.

Beam Therapeutics Inc. trades at a relatively cheap valuation based on its multiples and potential in SCD. Learn more about ...

That's the secret according to Dorothy Malcolm, who at 100-years-old, is one of Northern Ireland's growing number of ...

Indian researchers identify blood markers for early diabetes and kidney risk, enabling personalized treatment and timely interventions.

Iowa's oldest living person died at the age of 115 in 2023. Ames native Colleen Larson turned 100 years old this fall, a ...

BOOST Pharma ApS, a clinical-stage biopharmaceutical company focused on developing novel cell therapies for rare skeletal pediatric diseases, today announced that Sound Bioventures has joined its ...

In the run up to the launch of the latest series of The Kardashians, her new legal drama All's Fair and the celebrations for ...

Only two days after Bridgebio Pharma Inc. impressed investors with data from BBP-418 in limb-girdle muscular dystrophy type 2I/R9, the company was back at it again, this time reporting positive ...

The Trump administration is proud to bequeath to the University this list of courses bound to get you in accordance with the ...

The presentation will provide two-year follow-up data from the landmark BOOSTB4 Phase I/II clinical study. Notably, the results demonstrate that more than 50% of the treated patients experienced zero ...